Opportunity Information: Apply for PAR 21 061

The Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed), PAR-21-061, is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH) designed to strengthen and diversify the basic cancer research workforce. The central goal is to recruit and support junior investigators and Early Stage Investigators who come from groups that are nationally underrepresented in biomedical, behavioral, clinical, and social science research fields. In practical terms, the program aims to help talented early-career researchers gain a foothold in basic cancer research by providing support for exploratory, early-stage projects that can generate preliminary data, sharpen a research direction, and position investigators to compete successfully for larger, longer-term NIH research grants later on.

This FOA also functions as a bridge for investigators who have completed their research training but may need additional time and resources to transition to independence. That bridge aspect is important because it acknowledges a common gap between finishing formal training (such as postdoctoral work) and being ready to submit a strong, full-scale research project grant application. By backing smaller, exploratory studies in basic cancer research, the R21 mechanism can help investigators demonstrate feasibility, establish a track record, and develop a compelling scientific narrative that supports the next step in their funding trajectory.

The announcement is explicitly limited to non-clinical trial research, meaning clinical trials are not allowed under this opportunity. The emphasis is on basic cancer research, with the exploratory R21 structure typically suited to high-impact ideas that may still be in relatively early development stages. The funding instrument is a grant, and the activity category is listed under Education and Health, with CFDA number 93.393, aligning it with NIH cancer-related research support programs.

Eligibility is broad across many U.S.-based organization types, reflecting NIH’s intention to reach investigators working in a wide range of institutional settings. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also highlights a set of institutional categories often associated with serving historically underrepresented populations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes eligibility for faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions.

At the same time, the FOA places firm limits on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible. In addition, foreign components as defined by the NIH Grants Policy Statement are not allowed. These restrictions mean applications must be fully anchored in eligible domestic organizations and cannot include foreign components as part of the proposed project structure.

Key administrative details from the source listing include the opportunity category as discretionary, a creation date of March 18, 2021, and an original closing date of November 17, 2023. The listing does not provide an award ceiling or expected number of awards in the provided fields, so applicants typically would need to consult the full FOA text and NIH guidance for budget structure, project period parameters, and any institute-specific considerations. Overall, this program is best understood as an early-career, exploratory funding pathway focused on building a more representative basic cancer research community while helping investigators generate the foundation needed for future, larger-scale grant support.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
  • This funding opportunity was created on 2021-03-18.
  • Applicants must submit their applications by 2023-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 061

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)

Previous opportunity: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 061

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 061) also looked into and applied for these:

Funding Opportunity
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) Apply for PAR 21 183

Funding Number: PAR 21 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 21 036

Funding Number: RFA CA 21 036
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed) Apply for RFA LM 21 001

Funding Number: RFA LM 21 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 21 206

Funding Number: PAR 21 206
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,000
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Apply for PAR 21 166

Funding Number: PAR 21 166
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,000
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 21 208

Funding Number: PAR 21 208
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional) Apply for RFA AI 21 023

Funding Number: RFA AI 21 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 025

Funding Number: RFA AI 21 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 024

Funding Number: RFA AI 21 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 002

Funding Number: RFA DA 22 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) Apply for PAR 21 213

Funding Number: PAR 21 213
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 22 019

Funding Number: RFA DA 22 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 22 021

Funding Number: RFA DA 22 021
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) Apply for RFA CA 21 029

Funding Number: RFA CA 21 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Apply for RFA DA 22 001

Funding Number: RFA DA 22 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) Apply for RFA CA 21 031

Funding Number: RFA CA 21 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $875,000
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) Apply for PA 21 180

Funding Number: PA 21 180
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) Apply for RFA DA 22 007

Funding Number: RFA DA 22 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) Apply for RFA DA 22 005

Funding Number: RFA DA 22 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 024

Funding Number: RFA DA 22 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 061", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: